Stock Option

Adicet Bio, Inc. announced an inducement award to a new employee joining in September 2025. The individual received a non-qualified stock option to purchase 9,800 shares at $0.81 per share, the closing price on the grant date. The options vest over four years with a one-year cliff, contingent upon continued employment. The award was granted under the 2022 Inducement Plan and approved by the independent compensation committee, adhering to Nasdaq Listing Rule 5635(c)(4). Adicet Bio focuses on allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.